Suessenbach, Fabian Konstantin <br/><br/>
A quality control system for ligand-binding assay of plasma renin activity: Proof-of-concept within a pharmacodynamic study.  [electronic resource] 

 -  Journal of pharmaceutical and biomedical analysis  Mar 2020 
 - 113090 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Validation Study 
<br/><br/><label>ISSN: </label>1873-264X 
<br/><br/><label>Standard No.: </label>10.1016/j.jpba.2019.113090  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Child<br/>Child, Preschool<br/>Drug Monitoring--methods<br/>Enalapril--pharmacology<br/>Enzyme-Linked Immunosorbent Assay--standards<br/>Female<br/>Heart Failure--blood<br/>Humans<br/>Infant<br/>Male<br/>Prognosis<br/>Proof of Concept Study<br/>Quality Control<br/>Renin--blood<br/>Renin-Angiotensin System--physiology<br/>Reproducibility of Results